Paul D Loprinzi Selected Research

Cotinine

6/2016	Survival effects of physical activity on mortality among persons with liver disease.
1/2016	The association of serum cotinine and congestive heart failure diagnosis among never smokers: Considerations by physical activity behavior.
1/2016	Joint effects of objectively-measured sedentary time and physical activity on all-cause mortality.
1/2016	Health Behavior Combinations and Their Association With Inflammation.
3/2015	Nicotine Dependence, Physical Activity, and Sedentary Behavior among Adult Smokers.
9/2014	Physical activity moderates the association between nicotine dependence and depression among U.S. smokers.
1/2014	Influence of visual acuity on anxiety, panic and depression disorders among young and middle age adults in the United States.
11/2013	Association between physical activity and major depressive disorder among current or former smokers with pulmonary disease.
7/2013	Accelerometer-assessed physical activity and objectively determined dual sensory impairment in US adults.
1/2013	Effect of physical activity and sedentary behavior on serum prostate-specific antigen concentrations: results from the National Health and Nutrition Examination Survey (NHANES), 2003-2006.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul D Loprinzi Research Topics

Disease

15	Cardiovascular Diseases (Cardiovascular Disease) 06/2017 - 03/2015
7	Inflammation (Inflammations) 02/2019 - 09/2013
6	Chronic Disease (Chronic Diseases) 03/2018 - 03/2014
5	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2019 - 11/2014
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 06/2012
5	Heart Failure 01/2018 - 01/2016
4	Hypertension (High Blood Pressure) 01/2021 - 03/2015
4	Tobacco Use Disorder (Nicotine Dependence) 03/2015 - 06/2013
3	Pain (Aches) 05/2019 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 03/2016
2	Hypoxia (Hypoxemia) 11/2019 - 02/2019
2	Obesity 07/2018 - 11/2016
2	Neoplasms (Cancer) 01/2018 - 03/2014
2	Fatigue 01/2018 - 01/2012
2	Coronary Disease (Coronary Heart Disease) 11/2016 - 04/2016
2	Insulin Resistance 04/2016 - 05/2015
2	Overweight 10/2015 - 03/2015
2	Metabolic Diseases (Metabolic Disease) 03/2015 - 01/2014
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2014 - 01/2014
1	Tetanus 09/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Intellectual Disability (Idiocy) 01/2019
1	Atherosclerosis 01/2019
1	Cognitive Dysfunction 01/2019
1	Neck Pain (Cervicalgia) 03/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Myalgia 01/2018
1	Stroke (Strokes) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Tremor (Tremors) 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Liver Diseases (Liver Disease) 06/2016
1	Lung Diseases (Lung Disease) 04/2016
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2016
1	Abdominal Obesity 01/2016
1	Erectile Dysfunction 11/2015
1	Emphysema 03/2015
1	Bronchitis 03/2015
1	Mobility Limitation (Difficulty Walking) 10/2014
1	Panic Disorder (Panic Attack) 01/2014
1	Anxiety Disorders (Anxiety Disorder) 01/2014
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2014
1	Asthma (Bronchial Asthma) 11/2013
1	Frailty 07/2013
1	Deaf-Blind Disorders 07/2013
1	Body Weight (Weight, Body) 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Weight Gain 01/2012

Drug/Important Bio-Agent (IBA)

17	C-Reactive ProteinIBA 01/2021 - 01/2013
17	Biomarkers (Surrogate Marker)IBA 07/2017 - 07/2013
10	CotinineIBA 06/2016 - 01/2013
7	CholesterolIBA 01/2018 - 01/2013
6	Triglycerides (Triacylglycerol)IBA 01/2017 - 01/2013
5	Retinaldehyde (Retinal)IBA 02/2019 - 11/2014
5	HDL CholesterolIBA 01/2017 - 01/2013
5	HomocysteineIBA 04/2016 - 06/2012
5	Nicotine FDA Link 01/2016 - 06/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2013
3	Mydriatics (Cycloplegics)IBA 02/2019 - 01/2018
3	Biological ProductsIBA 07/2018 - 01/2013
3	AlbuminsIBA 01/2017 - 09/2016
3	Indicators and Reagents (Reagents)IBA 10/2016 - 11/2015
2	Therapeutic UsesIBA 01/2020 - 11/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2017 - 04/2016
2	Alanine Transaminase (SGPT)IBA 06/2016 - 06/2016
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 06/2016 - 06/2016
2	BilirubinIBA 03/2015 - 01/2014
1	A 17 (A-17)IBA 01/2021
1	LipidsIBA 01/2021
1	T-18 (T 18)IBA 09/2020
1	Oxygen (Dioxygen)IBA 02/2019
1	LatexIBA 02/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	IronIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	PotassiumIBA 12/2016
1	AT 61IBA 12/2016
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 11/2016
1	LDL CholesterolIBA 04/2016
1	Hemoglobins (Hemoglobin)IBA 04/2016
1	Insulin (Novolin)FDA Link 04/2016
1	FlavonoidsIBA 11/2014
1	A-factor (Streptomyces)IBA 10/2014
1	VitaminsIBA 09/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2014
1	Vitamin E FDA LinkGeneric 01/2013
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2013
1	CarbohydratesIBA 01/2013
1	Dietary Fiber FDA Link 01/2013

Therapy/Procedure

4	Tai Ji (Tai Chi Chuan) 05/2019 - 01/2019
3	Therapeutics 01/2018 - 01/2012
2	Qigong (Qi Gong) 01/2019 - 01/2019
2	Meditation 03/2018 - 01/2018
2	Glycemic Control 11/2014 - 01/2014
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2019
1	Resistance Training 01/2017
1	Deep Brain Stimulation 01/2017
1	Cardiac Rehabilitation 03/2016